First Name: Daniel
Last Name: Armstrong
Position Title: Professor & Executive Vice Chair, Department of Pediatrics; Director, Mailman Center for Child Development and Director, University of Miami Sickle Cell Center, University of Miami Miller School of Medicine
Associate Chief of Staff, Holtz Children's Hospital
Job Responsibilities: Combination of Research and Patient Care, Department & Hospital Leadership/Administration
About Me/My interests: My research focuses on neurodevelopmental outcomes of childhood cancer, sickle cell disease, HIV. The current efforts are on identifying biologic (e.g, chronic anemia, chronic inflammatory processes, and biochemical pathway disruptions) and genetic risk factors for neurocognitive outcomes to better understand mechanisms that can be modified, and developing and evaluating innovative approaches to intervention and prevention. We are beginning to look at outcomes in adults who are long-term survivors of these chronic illnesses, and at models of clinical-community and community-public policy translation research, particularly in the area of health disparities.
Training Opportunities: Yes
My Contact Information:
Address: P.O. Box 016820 (D-820), Miami, FL 33101
Topics of Interest for Collaboration: Neurocognitive outcomes, childhood cancer, sickle cell disease, health disparities, translation research
Publications that may be of interest to others:
Armstrong, F.D. (2013). Invited Editorial: Implications of 25-year follow-up of white matter integrity and neurocognitive function of childhood leukemia survivors: A wake-up call. Journal of Clinical
Oncology, 31, 3309-3311. Published ahead of print onAugust 19, 2013.
Armstrong,F.D. (2012). Invited Editorial: Proton-beam radiation therapy and health-related quality of life in children with central
nervous system tumors. Journal of Clinical Oncology, 30, 2028-2029.
Published ahead of print on May 7, 2012 as 10.1200/JCO.2012.42.1248,
Duffner, P.K., Armstrong, F.D., Chen, L., Helton, K., Brecher, M.L.,
Bell, B., & Chauvenet , A.R. (2014). Neurocognitive and neuroradiologic
central nervous system late effects in children with acute lymphoblastic
leukemia treated on POG 9605 and 9201 (ACCL0131): A methotrexate
consequence? A report from the Children¹s Oncology Group. Journal of Pediatric Hematology Oncology, 31 (1), 8-15.
Ris, M.D., Walsh, K., Armstrong, F.D., Wallace, D., Holms, E., Gajjar,
A., Zhou, T., & Packer, R. (2013). Intellectual and academic outcome
following two chemotherapy regimens and radiotherapy for average risk medulloblastoma: COG A9961. Pediatric Blood and Cancer. (DOI
10.1002/pbc.24496). Published online February 26, 2013.
Armstrong, F.D. (February, 2014). Benefits of modified craniospinal
radiation therapy for children treated for medulloblastoma: Preserving long-term neurocognitive function. Invited Podcast. Journal of Clinical